Comprehensive genomic profiling identifies a novel TNKS2-PDGFRA fusion that defines a myeloid neoplasm with eosinophilia that responded dramatically to imatinib therapy

全面的基因组分析发现了一种新的TNKS2-PDGFRA融合基因，该基因定义了一种伴有嗜酸性粒细胞增多的髓系肿瘤，该肿瘤对伊马替尼治疗反应显著。